Yankai Xia Selected Research

Oligospermia (Oligozoospermia)

10/2018	Idiopathic male infertility is strongly associated with aberrant DNA methylation of imprinted loci in sperm: a case-control study.
9/2015	A genome-wide association study of mitochondrial DNA in Chinese men identifies two risk single nucleotide substitutions for idiopathic oligoasthenospermia.
7/2014	Urinary metabolome identifies signatures of oligozoospermic infertile men.
12/2012	Genetic variants in epoxide hydrolases modify the risk of oligozoospermia and asthenospermia in Han-Chinese population.
10/2012	Seminal plasma microRNAs: potential biomarkers for spermatogenesis status.
12/2010	Genetic variants in Piwi-interacting RNA pathway genes confer susceptibility to spermatogenic failure in a Chinese population.
9/2008	Polymorphisms in CYP1A1 gene are associated with male infertility in a Chinese population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yankai Xia Research Topics

Disease

27	Male Infertility (Male Sterility) 04/2020 - 09/2008
15	Hirschsprung Disease (Hirschsprung's Disease) 01/2021 - 08/2014
14	Neoplasms (Cancer) 10/2020 - 10/2006
8	Infertility (Sterility) 01/2021 - 12/2010
8	Azoospermia 10/2018 - 07/2008
7	Obesity 07/2022 - 11/2015
7	Oligospermia (Oligozoospermia) 10/2018 - 09/2008
5	Gestational Diabetes (Gestational Diabetes Mellitus) 04/2021 - 01/2011
5	Carcinogenesis 01/2021 - 10/2006
5	Birth Weight (Birth Weights) 01/2020 - 10/2012
4	Lung Neoplasms (Lung Cancer) 08/2018 - 06/2016
3	Spontaneous Abortion (Miscarriage) 01/2022 - 09/2013
3	Inflammation (Inflammations) 09/2021 - 12/2018
3	Premature Birth (Birth, Premature) 01/2021 - 08/2018
3	Chromosome Aberrations (Chromosome Abnormalities) 05/2005 - 05/2004
2	COVID-19 02/2021 - 01/2021
2	Dysbiosis 11/2020 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 11/2016
2	Adenocarcinoma of Lung 01/2019 - 01/2016
2	Asthenozoospermia 07/2018 - 12/2015
2	Disease Progression 01/2017 - 07/2015
2	Neoplasm Metastasis (Metastasis) 06/2016 - 05/2015
2	Endometriosis 09/2014 - 11/2012
2	Calculi (Calculus) 11/2007 - 10/2006
1	Diabetes Mellitus 02/2022
1	Sarcoma (Soft Tissue Sarcoma) 06/2021
1	Congenital Abnormalities (Deformity) 02/2021
1	Autism Spectrum Disorder 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Pre-Eclampsia (Preeclampsia) 01/2021
1	Ganglion Cysts (Ganglion) 01/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2020
1	Stomach Neoplasms (Stomach Cancer) 11/2020
1	Body Weight (Weight, Body) 10/2020
1	Asthma (Bronchial Asthma) 08/2020

Drug/Important Bio-Agent (IBA)

16	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2011
10	Biological ProductsIBA 01/2021 - 05/2004
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2013
7	Long Noncoding RNAIBA 07/2019 - 01/2016
6	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 09/2012
6	Particulate MatterIBA 08/2020 - 06/2016
6	Proteins (Proteins, Gene)FDA Link 10/2019 - 11/2007
4	Competitive Endogenous RNAIBA 05/2019 - 01/2017
4	PhenolsIBA 01/2019 - 01/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 12/2010
4	ORALIT (ORS)IBA 12/2017 - 06/2009
3	CytokinesIBA 02/2021 - 11/2020
3	Interleukin-6 (Interleukin 6)IBA 02/2021 - 12/2018
3	ArsenicIBA 01/2021 - 08/2013
3	Circular RNAIBA 01/2021 - 01/2017
3	Environmental Pollutants (Pollutants, Environmental)IBA 08/2020 - 08/2018
3	PesticidesIBA 01/2020 - 10/2012
3	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 08/2014 - 09/2008
3	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 12/2010 - 05/2009
2	Triclosan (pHisoHex)FDA Link 07/2022 - 12/2015
2	BariumIBA 01/2022 - 01/2021
2	Trace Elements (Biometals)IBA 01/2022 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 06/2021 - 07/2013
2	Interleukin-10 (Interleukin 10)IBA 02/2021 - 01/2021
2	Untranslated RNA (Noncoding RNA)IBA 01/2021 - 01/2019
2	celastrolIBA 10/2020 - 07/2016
2	phthalic acid (phthalate)IBA 01/2019 - 12/2017
2	Mitochondrial DNA (mtDNA)IBA 10/2018 - 08/2017
2	Air Pollutants (Pollutants, Air)IBA 08/2018 - 08/2018
2	UridineIBA 07/2016 - 08/2013
2	Aluminum Oxide (Sapphire)IBA 01/2016 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2016 - 08/2015
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 05/2015 - 08/2014
2	EnzymesIBA 08/2014 - 01/2013
2	Phytoestrogens (Phytoestrogen)IBA 08/2014 - 09/2013
2	Aspartic Acid (Aspartate)FDA Link 06/2014 - 08/2013
2	Hormones (Hormone)IBA 06/2014 - 08/2013
2	Messenger RNA (mRNA)IBA 01/2013 - 10/2006
2	3' Untranslated Regions (3' UTR)IBA 12/2010 - 07/2008
2	terephthalic acid (terephthalate)IBA 11/2007 - 10/2006
1	Insulin (Novolin)FDA Link 02/2022
1	ElementsIBA 01/2022
1	CopperIBA 01/2022
1	RubidiumIBA 01/2022
1	Polyethylene (Polythene)IBA 09/2021
1	MucinsIBA 09/2021
1	MicroplasticsIBA 09/2021
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2021
1	ZincIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	AzoxymethaneIBA 01/2021
1	MetalsIBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	StrontiumIBA 01/2021
1	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2021
1	Fibrinogen (Factor I)FDA Link 01/2021
1	CarcinogensIBA 01/2021
1	GlucocorticoidsIBA 11/2020

Therapy/Procedure

3	Therapeutics 11/2020 - 04/2014
1	Folfox protocol 11/2020
1	Drug Therapy (Chemotherapy) 11/2020